Back to search results

Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

TNBC · TNBC - Triple-Negative Breast Cancer · Early Stage Triple-Negative Breast Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Cedars-Sinai Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Clinical Trial Recruitment Navigator) · GroupCancerTrialInformation@cshs.org · 310-423-2133
    Contact: Principal Investigator (Yuan Yuan, MD, PhD)

  • Cedars-Sinai Medical Center Beverly Hills, Los Angeles, California, United States

    Contact: Study coordinator (Clinical Trial Recruitment Navigator) · GroupCancerTrialInformation@cshs.org · 310-423-2133
    Jin Sun Bitar, MD (Sub-investigator)
    Stephen Shiao, MD, PhD (Sub-investigator)
    Dorothy Park, MD (Sub-investigator)
    Maryliza El-Masry, MD (Sub-investigator)
    Philomena McAndrew, MD (Sub-investigator)

  • Huntington Cancer Center, an Affiliate of CS Cancer, Pasadena, California, United States

    Contact: Study coordinator (Clinical Trial Recruitment Navigator) · GroupCancerTrialInformation@cshs.org · 310-423-2133
    Niki Tank, MD (Sub-investigator)
    Tina Wang, MD (Sub-investigator)
    Tiffany Shaw, MD (Sub-investigator)

  • Hunt Cancer Institute, an Affiliate of CS Cancer, Torrance, California, United States

    Contact: Study coordinator (Sarah Valdez) · sarah.valdez@tmphysicians.com · 310-750-3300
    Swati Sikaria, MD (Sub-investigator)
    David Chan, MD (Sub-investigator)
    Vanessa Dickey, MD (Sub-investigator)
    Hugo Hool, MD (Sub-investigator)
    Andrew Horodner, MD (Sub-investigator)
    Syed Jilani, MD (Sub-investigator)
    Thomas Lowe, MD (Sub-investigator)
    Justin Tiulim, MD (Sub-investigator)
Study leads

  • Yuan Yuan, MD

    Principal Investigator

    Cedars-Sinai Medical Center

View source on ClinicalTrials.gov(opens in a new tab)